U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CVM GFI #268 Adaptive and Other Innovative Designs for Effectiveness Studies of New Animal Drugs
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

CVM GFI #268 Adaptive and Other Innovative Designs for Effectiveness Studies of New Animal Drugs July 2020

Draft

Not for implementation. Contains non-binding recommendations.

Docket Number:
FDA-2020-D-1401
Issued by:
Guidance Issuing Office
Center for Veterinary Medicine

This draft guidance describes principles for designing, conducting, and reporting the results for investigations or studies, including adaptive design features, when they are incorporated into clinical investigations submitted to CVM to demonstrate substantial evidence of effectiveness for new animal drug applications or a reasonable expectation of effectiveness for applications for conditional approval of a new animal drug. It also provides information about how sponsors may obtain feedback from CVM on technical issues related to the use of adaptive and innovative designs before the submission of an application. 


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2020-D-1401.

Questions?

Back to Top